Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 4 , Pages 283-298, December 2005

The influence of photodynamic therapy on the immune response

Department of Immunology, Center of Biostructure Research, The Medical University of Warsaw, ul. Chałubińskiego 5, 02-004 Warsaw, Poland

published online 06 December 2005.

Summary 

Photodynamic therapy (PDT) is a clinically approved therapeutic modality used for the management of several types of tumors as well as non-malignant diseases. Most of the effects of this treatment regimen result from direct action of singlet oxygen and reactive oxygen species. However, accumulating evidence indicates that antitumor effects are also mediated by indirect stimulation of inflammatory and immune responses. These responses include rapid local infiltration of tumors by neutrophils and macrophages accompanied by systemic release of inflammatory mediators. This early response can initiate and translate into a more precise immune reaction that involves activation of specific T lymphocytes that seem to be necessary for the ultimate control of residual tumor cells. Although still incompletely understood, PDT can not only activate but also suppress the immune response depending on several variables. This review summarizes the influence of PDT on the immune response and discusses its importance in the management of human diseases.

Abbreviations: 8-MOP, 8-methoxypsoralen, BCG, Bacillus Calmette-Guerin, ALA, 5-aminolevulinic acid, CD, cluster of differentiation, CHS, contact hypersensitivity, DBPMAF, Vitamin D3-binding protein-derived macrophage-activating factor, DC, dendritic cells, EAE, experimental autoimmune encephalomyelitis, ECP, extracorporeal photochemotherapy, G-CSF, granulocyte colony-stimulating factor, GM-CSF, granulocyte-macrophages colony-stimulating factor, GVHD, graft-versus-host disease, GVL, graft versus leukemia, HLA, human leukocyte antigen, HSP, heat shock protein, IFN, interferon, KC, keratinocytes-derived chemokines, MAC, membrane attack complex, MHC, major histocompatibility complex, MIP, macrophage inflammatory protein, MPO, myeloperoxidase, MS, multiple sclerosis, NK, natural killer, NO, nitric oxide, PDT, photodynamic therapy, PIT, photoimmunotherapy, SOD, superoxide dismutase, TAA, tumor-associated antigen, TGF-β, transforming growth factor-β, TLR, Toll-like receptor, TNF, tumor necrosis factor, TRAIL, TNF-related apoptosis-inducing ligand, UVA, ultraviolet A

Keywords: Photodynamic therapy, Tumor, Immune response, Inflammation, Dendritic cells

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1572-1000(05)00098-0

doi:10.1016/S1572-1000(05)00098-0

Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 4 , Pages 283-298, December 2005